Dr Reddys Laboratories (RDY) Cost of Revenue (2009 - 2023)
Dr Reddys Laboratories (RDY) posted quarterly Cost of Revenue of $342.0 million for Q2 2023, up 2.09% quarter-over-quarter from $335.0 million in Q1 2023.
Dr Reddys Laboratories (RDY) Cost of Revenue (2009 - 2023) Analysis & Trends
Dr Reddys Laboratories' Cost of Revenue history runs 15 years deep, the most recent figure standing at $342.0 million for Q2 2023.
- In Q2 2023, Cost of Revenue changed N/A year-over-year to $342.0 million; the TTM figure through Jun 2023 stood at $336001.0 billion (changed N/A YoY), while the FY2026 annual figure was $1.7 billion, up 6.96% from the prior year.
- Cost of Revenue for Q2 2023 stood at $342.0 million, up from $335.0 million in the prior quarter.
- The five-year high for Cost of Revenue was $336000.0 billion in Q3 2022, with the low at $263.0 million in Q1 2019.
- The 5-year median for Cost of Revenue is $314.5 million (2020), against an average of $28000.3 billion.
- The sharpest annual moves came in 2019 and 2020: Cost of Revenue advanced 21.7% in 2019, then gained 0.38% in 2020.
- Dr Reddys Laboratories' Cost of Revenue stood at $282.0 million in 2019, then climbed by 10.64% to $312.0 million in 2020, then advanced by 16.03% to $362.0 million in 2021, then dropped by 9.12% to $329.0 million in 2022, then gained by 3.95% to $342.0 million in 2023.
- Business Quant data shows RDY's Cost of Revenue at $342.0 million in Q2 2023, $335.0 million in Q1 2023, and $329.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | 98.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 342.00 Mn |
| Jun 30, 2023 | 342.00 Mn |
| Mar 31, 2023 | 335.00 Mn |
| Mar 31, 2023 | 335.00 Mn |
| Dec 31, 2022 | 329.00 Mn |
| Dec 31, 2022 | 329.00 Mn |
| Sep 30, 2022 | 336,000.00 Bn |
| Sep 30, 2022 | 336,000.00 Bn |
| Jun 30, 2021 | 362.00 Mn |
| Jun 30, 2021 | 362.00 Mn |
| Mar 31, 2021 | 317.00 Mn |
| Mar 31, 2021 | 317.00 Mn |
| Sep 30, 2020 | 312.00 Mn |
| Sep 30, 2020 | 312.00 Mn |
| Jun 30, 2020 | 309.00 Mn |
| Jun 30, 2020 | 309.00 Mn |
| Mar 31, 2020 | 264.00 Mn |
| Mar 31, 2020 | 264.00 Mn |
| Sep 30, 2019 | 282.00 Mn |
| Sep 30, 2019 | 282.00 Mn |